ROCKET PHARMACEUTICALS, INC. — All Filings
898 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
3/A
305B2
4
4/A
424B2
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFM14A
DEL AM
DRS
DRS/A
EFFECT
FWP
POS AM
PRE 14A
PREM14A
PRER14A
PX14A6G
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002213 | Mar 27, 2026 | — |
| 8-K | 8-K | 0001140361-26-011573 | Mar 27, 2026 | Mar 26, 2026 |
| PRE 14A | PRE 14A | 0001140361-26-010967 | Mar 25, 2026 | May 20, 2026 |
| EFFECT | — | 9999999995-26-000767 | Mar 10, 2026 | — |
| 8-K | 8-K | 0001140361-26-008853 | Mar 10, 2026 | — |
| 424B5 | 424B5 | 0001140361-26-008849 | Mar 10, 2026 | — |
| S-3 | S-3 | 0001140361-26-007341 | Mar 2, 2026 | — |
| 8-K | 8-K | 0001140361-26-006981 | Feb 26, 2026 | — |
| 10-K | 10-K | 0001193125-26-076551 | Feb 26, 2026 | Dec 31, 2025 |
| 4 | FORM 4 | 0001140361-26-006330 | Feb 20, 2026 | Feb 18, 2026 |
| 4 | FORM 4 | 0001140361-26-006326 | Feb 20, 2026 | Feb 18, 2026 |
| 4 | FORM 4 | 0001140361-26-006317 | Feb 20, 2026 | Feb 18, 2026 |
| 4 | FORM 4 | 0001140361-26-006047 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0001140361-26-006045 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0001140361-26-006043 | Feb 18, 2026 | Feb 13, 2026 |
| 144 | — | 0001959173-26-001181 | Feb 18, 2026 | — |
| 144 | — | 0001959173-26-001176 | Feb 18, 2026 | — |
| 144 | — | 0001959173-26-001175 | Feb 18, 2026 | — |
| 144 | — | 0001959173-26-001000 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0001012975-26-000137 | Feb 13, 2026 | — |
| 4 | FORM 4 | 0001140361-26-005412 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | FORM 4 | 0001140361-26-005411 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | FORM 4 | 0001140361-26-005410 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | FORM 4 | 0001140361-26-005409 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | FORM 4 | 0001140361-26-005408 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | FORM 4 | 0001140361-26-005407 | Feb 13, 2026 | Feb 11, 2026 |
| 144 | — | 0001959173-26-000994 | Feb 13, 2026 | — |
| 144 | — | 0001959173-26-000992 | Feb 13, 2026 | — |
| 144 | — | 0001959173-26-000986 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0000102909-26-000302 | Jan 30, 2026 | — |
| 4 | FORM 4 | 0001140361-26-000378 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001140361-25-042856 | Nov 20, 2025 | Nov 18, 2025 |
| 4 | FORM 4 | 0001140361-25-042857 | Nov 20, 2025 | Nov 18, 2025 |
| 4 | FORM 4 | 0001140361-25-042855 | Nov 20, 2025 | Nov 18, 2025 |
| 4 | FORM 4 | 0001140361-25-042854 | Nov 20, 2025 | Nov 18, 2025 |
| 144 | — | 0001959173-25-007115 | Nov 18, 2025 | — |
| 144 | — | 0001959173-25-007109 | Nov 18, 2025 | — |
| 144 | — | 0001959173-25-007107 | Nov 18, 2025 | — |
| 144 | — | 0001959173-25-007106 | Nov 18, 2025 | — |
| 4 | FORM 4 | 0001140361-25-041393 | Nov 10, 2025 | Nov 3, 2025 |
| 10-Q | 10-Q | 0001193125-25-269474 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001140361-25-040774 | Nov 6, 2025 | — |
| 4 | FORM 4 | 0001140361-25-038302 | Oct 16, 2025 | Oct 14, 2025 |
| 144 | — | 0001959173-25-006434 | Oct 14, 2025 | — |
| 8-K | 8-K | 0001140361-25-038030 | Oct 14, 2025 | — |
| 4 | FORM 4 | 0001140361-25-037683 | Oct 8, 2025 | Oct 6, 2025 |
| 4 | FORM 4 | 0001140361-25-037275 | Oct 3, 2025 | Sep 24, 2025 |
| 3 | FORM 3 | 0001140361-25-037273 | Oct 3, 2025 | Sep 24, 2025 |
| 8-K | 8-K | 0001140361-25-037237 | Oct 3, 2025 | Sep 29, 2025 |
| 8-K | 8-K | 0001140361-25-037163 | Oct 3, 2025 | — |